Ishan Dyes and Chemicals LimitedQ1 FY27 Results & Financial Update
Ishan Dyes and Chemicals Limited: Q1 FY27 standalone results and company financials – revenue ₹41.48 Cr, PAT ₹0.16 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Ishan Dyes and Chemicals price & chart
Market price₹44.61
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Ishan Dyes and Chemicals Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Ishan Dyes and Chemicals Limited reported standalone revenue from operations of INR 41.48 crore for the quarter ended June 30, 2026.
Total income for Q1 FY27 reached INR 42.84 crore, bolstered by INR 1.36 crore in other income.
Profit before tax (PBT) stood at INR 0.18 crore after absorbing total expenses of INR 42.66 crore during the period.
Net profit after tax (PAT) for the quarter was recorded at INR 0.155 crore, resulting in a basic and diluted earnings per share of INR 0.06.
Cost of materials consumed formed the largest expense component at INR 30.59 crore, accompanied by changes in inventories of finished goods, work-in-progress, and stock-in-trade amounting to a negative INR 11.07 crore.
Finance costs and depreciation and amortisation expenses stood at INR 2.50 crore and INR 2.05 crore respectively for the quarter.
Statutory auditors M/s A R Sulakhe & Co issued a qualified conclusion on the standalone financial results, noting that certain inventories of finished goods held against specific customer contracts were valued above cost, contrary to Ind AS 2.
01 · Business model
What does Ishan Dyes and Chemicals do?
Ishan Dyes and Chemicals Limited operates in the chemical manufacturing sector, with its registered office and manufacturing facility situated in Vatva, Ahmedabad, Gujarat.
The company's primary operational focus centers on chemical manufacturing and related commercial activities within a single reportable business segment as per Ind AS 108.
Commercial operations are managed from its facilities in Phase-I of the GIDC Estate in Vatva, serving domestic and broader market requirements.
02 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹41.48 Cr |
| Total income | ₹42.84 Cr |
| Profit before tax | ₹0.18 Cr |
| Profit after tax | ₹0.16 Cr |
| EPS | ₹0.06 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 0.4% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 0.4% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹1.36 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
03 · Why it moved
Why the quarter looked the way it did
What drove revenue
Net sales/income from operations for Q1 FY27 was reported at INR 41.48 crore.
The company recorded INR 1.36 crore in other income, bringing total income to INR 42.84 crore.
What drove margins
Cost of materials consumed stood at INR 30.59 crore during the quarter.
Changes in inventories of finished goods, work-in-progress, and stock-in-trade resulted in a negative adjustment of INR 11.07 crore.
Employee benefits expense was INR 0.17 crore, while other expenses totalled INR 2.23 crore.
04 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
In line with Ind AS 108 on operating segments, the company maintains one reportable business segment, which is Chemicals.
05 · Pressure points & risks
What is not going smoothly
Statutory auditors issued a qualified conclusion due to the valuation of certain finished goods inventories held against specific customer contracts above cost, which is not in conformity with Ind AS 2. The overstatement of INR 284.78 lakhs from March 31, 2026 remains uncorrected in opening balances.
06 · Beyond the numbers
What changed beyond the numbers
Reported update
Annual General Meeting
The Board approved holding the 33rd Annual General Meeting of the company on Tuesday, September 29, 2026, through video conferencing or other audio-visual means.
07 · Key Q&A
The quarter, answered directly
What does Ishan Dyes and Chemicals do?
Ishan Dyes and Chemicals Limited operates in the chemical manufacturing sector, with its registered office and manufacturing facility situated in Vatva, Ahmedabad, Gujarat.
What is the clearest takeaway from Q1 FY27?
Ishan Dyes and Chemicals Limited reported standalone revenue from operations of INR 41.48 crore for the quarter ended June 30, 2026.
What drove revenue or demand?
Net sales/income from operations for Q1 FY27 was reported at INR 41.48 crore.
What mattered most for margins or profitability?
Cost of materials consumed stood at INR 30.59 crore during the quarter.
What changed operationally beyond the headline numbers?
The Board approved holding the 33rd Annual General Meeting of the company on Tuesday, September 29, 2026, through video conferencing or other audio-visual means.
What are the main pressure points disclosed for the quarter?
Statutory auditors issued a qualified conclusion due to the valuation of certain finished goods inventories held against specific customer contracts above cost, which is not in conformity with Ind AS 2. The overstatement of INR 284.78 lakhs from March 31, 2026 remains uncorrected in opening balances.
08 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
09 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Inventory Valuation Compliance: Resolution of the auditor qualification regarding inventory valuation under Ind AS 2 in subsequent financial periods.
- 02
Annual General Meeting Execution: Convening of the 33rd Annual General Meeting scheduled for September 29, 2026.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.